Brief: Bolt Biotherapeutics Reports First Quarter 2023 Financial Results And Provides Business Update
Bolt Biotherapeutics Inc BOLT.O :
* BOLT BIOTHERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* CASH BALANCE OF $171.0 MILLION ANTICIPATED TO FUND KEY
CLINICAL
MILESTONES THROUGH 2025
* QTRLY LOSS PER SHARE $0.45
* Q1 EARNINGS PER SHARE VIEW $-0.51 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX6dVjDb
Further company coverage: BOLT.O